Swedish Orphan Biovitrum AB (publ)
XMUN:B6E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Swedish Orphan Biovitrum AB (publ)
XMUN:B6E
|
SE |
|
T
|
Turbon AG
XMUN:TUR
|
DE |
|
Grupa Azoty Zaklady Chemiczne Police SA
F:697
|
PL |
|
T
|
Topaz Energy Corp
F:5XU
|
CA |
|
Siam Cement PCL
SET:SCC
|
TH |
|
ATHA Energy Corp
F:X5U
|
CA |
|
IP Group PLC
LSE:IPO
|
UK |
|
A
|
Arnoldo Mondadori Editore SpA
DUS:MDD
|
IT |
|
R
|
Repsol SA
SWB:REP
|
ES |
|
W
|
Waldencast PLC
NASDAQ:WALD
|
UK |
|
P
|
Prosper Gold Corp
OTC:PGXFF
|
CA |
|
HyPower Fuel Inc
OTC:HYPF
|
CA |
|
Associated Capital Group Inc
F:41J
|
US |
|
N
|
Navakij Insurance PCL
SET:NKI
|
TH |
|
W
|
Weichai Power Co Ltd
F:WI4
|
CN |
|
Petards Group PLC
LSE:PEG
|
UK |
|
International Prospect Ventures Ltd
XTSX:IZZ
|
CA |
|
N
|
NI Hsin Group Bhd
KLSE:NIHSIN
|
MY |
|
D
|
Derwent London PLC
F:DVK
|
UK |
|
North Arrow Minerals Inc
XTSX:NAR
|
CA |
|
C
|
Cerus Corp
SWB:CU2
|
US |
|
Citizens Bancshares Corp (South Carolina)
OTC:CITZ
|
US |
|
Repsol SA
F:REPA
|
ES |
|
T
|
Television Francaise 1 SA
XMUN:FSE
|
FR |
Bankruptcy Probability
Swedish Orphan Biovitrum AB (publ)'s probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Swedish Orphan Biovitrum AB (publ) Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
148.6B SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Swedish Orphan Biovitrum AB (publ)'s probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Swedish Orphan Biovitrum AB (publ) has total debt of 8.7B SEK. This includes both short-term (0 SEK) and long-term (8.7B SEK) debt.
You can find a full breakdown on its Balance Sheet.